Test To Detect Alzheimer’s Disease Before Symptoms Appear
Researchers at the Sahlgrenska Academy have amazing results regarding the possibility of detecting Alzheimer’s disease before symptoms appear. This is seen possible through the use of a cerebrospinal test to detect protein fragments that are released to the CSF which also causes the disease’s hallmark memory dysfunction and disorientation. This protein fragment called beta-amyloid forms clumps which are found between nerve cells of the brain hence memory loss.
The study, which was led by Kaj Biennow, a leading Alzheimer’s disease expert together with researchers at the University of Gothenburg’s Sahlgrenska Academy, found that there was a way to measure proteins and protein fragments in the CSF. This will ultimately reflect biological processes in the body that will also lead to an effective diagnosis of people with other cognitive disorders rather than Alzheimer’s.
Detection at an early state has always been the best option for most illnesses and Alzheimer’s disease is no exception. Since there are significant protein changes in the CSF, detection of this illness is possible. These changes have been called biomarkers and an international quality control program for the measurement of these biomarkers has also been established by the researchers in Gothenburg. Aside from accurate early diagnosis of Alzheimer’s disease, these biomarkers may also help create drugs that can be tested for this illness. Soon, the development of techniques to treat this condition at an early stage will also be possible. Researchers are positive that these biomarkers will change the way Alzheimer’s disease will be studies, diagnosed and treated in the future.